Free Trial

Pediatrix Medical Group (MD) Competitors

Pediatrix Medical Group logo
$12.76 -0.12 (-0.91%)
Closing price 03:59 PM Eastern
Extended Trading
$12.74 -0.03 (-0.22%)
As of 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MD vs. AMED, AMN, CCRN, DGX, LH, DVA, CHE, CRVL, SEM, and EHC

Should you be buying Pediatrix Medical Group stock or one of its competitors? The main competitors of Pediatrix Medical Group include Amedisys (AMED), AMN Healthcare Services (AMN), Cross Country Healthcare (CCRN), Quest Diagnostics (DGX), Laboratory Co. of America (LH), DaVita (DVA), Chemed (CHE), CorVel (CRVL), Select Medical (SEM), and Encompass Health (EHC).

Pediatrix Medical Group vs.

Amedisys (NASDAQ:AMED) and Pediatrix Medical Group (NYSE:MD) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment, dividends and community ranking.

Amedisys has higher revenue and earnings than Pediatrix Medical Group. Pediatrix Medical Group is trading at a lower price-to-earnings ratio than Amedisys, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Amedisys$2.37B1.31-$9.75M$2.7135.02
Pediatrix Medical Group$2.01B0.55-$60.41M-$1.20-10.77

Amedisys presently has a consensus target price of $100.75, indicating a potential upside of 6.16%. Pediatrix Medical Group has a consensus target price of $16.75, indicating a potential upside of 29.64%. Given Pediatrix Medical Group's stronger consensus rating and higher possible upside, analysts clearly believe Pediatrix Medical Group is more favorable than Amedisys.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Amedisys
0 Sell rating(s)
4 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.20
Pediatrix Medical Group
0 Sell rating(s)
4 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Amedisys has a beta of 0.89, suggesting that its share price is 11% less volatile than the S&P 500. Comparatively, Pediatrix Medical Group has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500.

Amedisys has a net margin of 3.57% compared to Pediatrix Medical Group's net margin of -4.92%. Pediatrix Medical Group's return on equity of 15.47% beat Amedisys' return on equity.

Company Net Margins Return on Equity Return on Assets
Amedisys3.57% 12.20% 6.74%
Pediatrix Medical Group -4.92%15.47%5.64%

94.4% of Amedisys shares are owned by institutional investors. Comparatively, 97.7% of Pediatrix Medical Group shares are owned by institutional investors. 2.1% of Amedisys shares are owned by insiders. Comparatively, 0.9% of Pediatrix Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, Amedisys had 23 more articles in the media than Pediatrix Medical Group. MarketBeat recorded 28 mentions for Amedisys and 5 mentions for Pediatrix Medical Group. Pediatrix Medical Group's average media sentiment score of 1.33 beat Amedisys' score of 1.04 indicating that Pediatrix Medical Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Amedisys
15 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Pediatrix Medical Group
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Pediatrix Medical Group received 11 more outperform votes than Amedisys when rated by MarketBeat users. Likewise, 60.14% of users gave Pediatrix Medical Group an outperform vote while only 58.63% of users gave Amedisys an outperform vote.

CompanyUnderperformOutperform
AmedisysOutperform Votes
496
58.63%
Underperform Votes
350
41.37%
Pediatrix Medical GroupOutperform Votes
507
60.14%
Underperform Votes
336
39.86%

Summary

Amedisys and Pediatrix Medical Group tied by winning 9 of the 18 factors compared between the two stocks.

Get Pediatrix Medical Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for MD and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MD vs. The Competition

MetricPediatrix Medical GroupHospitals IndustryMedical SectorNYSE Exchange
Market Cap$1.11B$5.09B$5.56B$18.97B
Dividend YieldN/A0.99%5.11%4.02%
P/E Ratio-10.7712.4422.4832.71
Price / Sales0.551.05394.5627.84
Price / Cash4.917.7938.1817.53
Price / Book1.452.406.774.47
Net Income-$60.41M$212.93M$3.22B$1.02B
7 Day Performance3.36%9.69%1.48%0.50%
1 Month Performance-10.92%5.10%3.99%-2.83%
1 Year Performance43.40%16.69%16.15%4.36%

Pediatrix Medical Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MD
Pediatrix Medical Group
2.0401 of 5 stars
$12.76
-0.9%
$16.75
+31.2%
+45.7%$1.10B$2.01B-10.647,850Upcoming Earnings
Positive News
AMED
Amedisys
2.9024 of 5 stars
$94.69
+0.2%
$100.75
+6.4%
+3.1%$3.11B$2.37B37.5820,000Analyst Revision
AMN
AMN Healthcare Services
4.2448 of 5 stars
$19.33
+0.7%
$38.67
+100.0%
-65.9%$738.19M$2.98B-5.024,230Upcoming Earnings
Analyst Revision
News Coverage
CCRN
Cross Country Healthcare
3.5199 of 5 stars
$13.51
-1.7%
$18.41
+36.2%
-23.0%$442.94M$1.34B-270.152,700Upcoming Earnings
Analyst Forecast
News Coverage
DGX
Quest Diagnostics
4.569 of 5 stars
$176.64
+1.7%
$185.07
+4.8%
+29.1%$19.72B$10.16B22.9749,000Analyst Forecast
Short Interest ↑
LH
Laboratory Co. of America
4.7227 of 5 stars
$230.45
+0.9%
$268.77
+16.6%
+19.6%$19.28B$13.01B26.1375,500Earnings Report
Analyst Forecast
Short Interest ↑
DVA
DaVita
4.2802 of 5 stars
$140.64
+0.8%
$166.33
+18.3%
+1.9%$11.25B$12.82B13.0970,000Positive News
CHE
Chemed
4.5788 of 5 stars
$565.32
+1.7%
$674.00
+19.2%
+2.0%$8.26B$2.49B28.5714,200Analyst Forecast
Positive News
CRVL
CorVel
0.9411 of 5 stars
$109.75
-0.5%
N/A+36.6%$5.64B$871.31M64.564,230News Coverage
Positive News
SEM
Select Medical
4.9879 of 5 stars
$18.16
+4.7%
$26.80
+47.6%
-35.6%$2.34B$5.19B11.0153,800Insider Trade
News Coverage
High Trading Volume
EHC
Encompass Health
4.4795 of 5 stars
$115.35
+1.7%
$120.86
+4.8%
+40.4%$11.62B$5.37B25.8635,000Earnings Report
Dividend Announcement
Analyst Forecast
Insider Trade
Analyst Revision
News Coverage
Positive News

Related Companies and Tools


This page (NYSE:MD) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners